A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV

A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV

The highly pathogenic coronaviruses SARS-CoV-2 and SARS-CoV have led to the COVID-19 pandemic and SARS outbreak, respectively. The receptor-binding domain (RBD) of the spike (S) protein of SARS-CoV-2, particularly the Omicron variant, has frequent mutations, resulting in the reduced efficiency of cu...

Full description

Bibliographic Details
Main Authors: Xiaoqing Guan, Abhishek K. Verma, Gang Wang, Abhijeet Roy, Stanley Perlman, Lanying Du
Format: Article
Language:English
Published: MDPI AG 2024-06-01
Series:Vaccines
Subjects:
coronavirus
COVID-19
SARS-CoV-2
SARS-CoV
spike protein
receptor-binding domain
Online Access:https://www.mdpi.com/2076-393X/12/6/605

Internet

https://www.mdpi.com/2076-393X/12/6/605

Similar Items